Narwhal Capital Management Sells 6,687 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Narwhal Capital Management reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,161 shares of the healthcare conglomerate’s stock after selling 6,687 shares during the period. UnitedHealth Group accounts for about 1.6% of Narwhal Capital Management’s investment portfolio, making the stock its 13th largest holding. Narwhal Capital Management’s holdings in UnitedHealth Group were worth $18,293,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Dark Forest Capital Management LP increased its holdings in shares of UnitedHealth Group by 76.9% during the second quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after acquiring an additional 319 shares in the last quarter. Forefront Analytics LLC raised its holdings in UnitedHealth Group by 6.4% in the second quarter. Forefront Analytics LLC now owns 877 shares of the healthcare conglomerate’s stock worth $449,000 after buying an additional 53 shares during the last quarter. Buck Wealth Strategies LLC purchased a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $7,112,000. Copperwynd Financial LLC raised its holdings in UnitedHealth Group by 24.2% in the 2nd quarter. Copperwynd Financial LLC now owns 1,775 shares of the healthcare conglomerate’s stock worth $904,000 after acquiring an additional 346 shares during the last quarter. Finally, Magnolia Capital Advisors LLC boosted its stake in UnitedHealth Group by 322.7% during the 2nd quarter. Magnolia Capital Advisors LLC now owns 13,661 shares of the healthcare conglomerate’s stock valued at $6,957,000 after purchasing an additional 10,429 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of research analyst reports. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $627.74.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $532.26 on Monday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The stock has a 50-day moving average price of $541.04 and a 200 day moving average price of $564.34.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.